Hydroxyprostaglandin Dehydrogenases
"Hydroxyprostaglandin Dehydrogenases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Catalyzes reversibly the oxidation of hydroxyl groups of prostaglandins.
Descriptor ID |
D006911
|
MeSH Number(s) |
D08.811.682.047.820.375
|
Concept/Terms |
Hydroxyprostaglandin Dehydrogenases- Hydroxyprostaglandin Dehydrogenases
- Dehydrogenases, Hydroxyprostaglandin
- Hydroxyprostaglandin Dehydrogenase
- Dehydrogenase, Hydroxyprostaglandin
- Prostacyclin Dehydrogenase
- Dehydrogenase, Prostacyclin
|
Below are MeSH descriptors whose meaning is more general than "Hydroxyprostaglandin Dehydrogenases".
Below are MeSH descriptors whose meaning is more specific than "Hydroxyprostaglandin Dehydrogenases".
This graph shows the total number of publications written about "Hydroxyprostaglandin Dehydrogenases" by people in this website by year, and whether "Hydroxyprostaglandin Dehydrogenases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2005 | 1 | 1 | 2 |
2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hydroxyprostaglandin Dehydrogenases" by people in Profiles.
-
KLF15 Is a transcriptional regulator of the human 17beta-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women. J Clin Endocrinol Metab. 2009 Jul; 94(7):2594-601.
-
Placental expression of enzymes regulating prostaglandin synthesis and degradation. Am J Obstet Gynecol. 2005 Jun; 192(6):1836-42; discussion 1842-3.
-
Characterization of the basal promoter element of the human type 5 17beta-hydroxysteroid dehydrogenase gene. Biochim Biophys Acta. 2005 May 01; 1728(3):115-25.
-
Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of toll-like receptor 4. Biol Reprod. 2003 Dec; 69(6):1957-63.
-
Polycyclic aromatic hydrocarbon quinones may be either substrates for or irreversible inhibitors of the human placental NAD-linked 15-hydroxyprostaglandin dehydrogenase. Arch Biochem Biophys. 1992 Jan; 292(1):239-43.
-
Purification of the human placental NAD-linked 15-hydroxyprostaglandin dehydrogenase. Prostaglandins. 1988 Aug; 36(2):205-13.
-
Inhibition of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases by nonsteroidal anti-inflammatory drugs. Prostaglandins. 1988 Mar; 35(3):403-11.
-
In vitro activity of nicotinamide adenine dinucleotide- and nicotinamide adenine dinucleotide phosphate-linked 15-hydroxyprostaglandin dehydrogenases in placentas from normotensive and preeclamptic/eclamptic pregnancies. J Clin Invest. 1987 Oct; 80(4):936-40.
-
Polycyclic aromatic hydrocarbon quinones and glutathione thioethers as substrates and inhibitors of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase. J Biol Chem. 1987 Sep 15; 262(26):12448-51.
-
Irreversible inhibition of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase/9-ketoprostaglandin reductase by glutathione thiosulfonate. Prostaglandins. 1987 Mar; 33(3):391-402.